A case series on the heightened autonomic response due to guanfacine and amphetamine interaction

J Clin Psychopharmacol. 2015 Apr;35(2):197-9. doi: 10.1097/JCP.0000000000000273.

Authors

Edward C Gaiser¹, David Matuskey, Evgenia Perkins, Cynthia D'Amico, Osama Abdelghany, Sherry A McKee, Kelly P Cosgrove

Affiliation

¹ Departments of Diagnostic Radiology and Psychiatry Yale University New Haven, CT edward.gaiser@yale.edu Departments of Diagnostic Radiology and Psychiatry Yale University New Haven, CT Department of Psychiatry Yale University New Haven, CT Department of Diagnostic Radiology Yale University New Haven, CT Investigational Drug Service Yale New Haven Hospital New Haven, CT Department of Psychiatry Yale University New Haven, CT Departments of Diagnostic Radiology Psychiatry, and Neurobiology Yale University New Haven, CT.

No abstract available

Publication types

Letter
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Research Support, U.S. Gov't, P.H.S.

MeSH terms

Adrenergic alpha-Agonists / adverse effects*
Amphetamine / adverse effects*
Attention Deficit Disorder with Hyperactivity / complications
Attention Deficit Disorder with Hyperactivity / drug therapy
Autonomic Nervous System Diseases / chemically induced*
Autonomic Nervous System Diseases / physiopathology
Blood Pressure / drug effects
Central Nervous System Stimulants / adverse effects*
Dopamine / metabolism
Drug Interactions
Guanfacine / adverse effects*
Humans

Substances

Adrenergic alpha-Agonists
Central Nervous System Stimulants
Guanfacine
Amphetamine
Dopamine

Grants and funding